EA200802402A1 - Применение антагонистов аденозинового a1-рецептора при индуцируемой радиоконтрастной средой нефропатии - Google Patents

Применение антагонистов аденозинового a1-рецептора при индуцируемой радиоконтрастной средой нефропатии

Info

Publication number
EA200802402A1
EA200802402A1 EA200802402A EA200802402A EA200802402A1 EA 200802402 A1 EA200802402 A1 EA 200802402A1 EA 200802402 A EA200802402 A EA 200802402A EA 200802402 A EA200802402 A EA 200802402A EA 200802402 A1 EA200802402 A1 EA 200802402A1
Authority
EA
Eurasian Patent Office
Prior art keywords
application
medium
induced
receptor
antagonists
Prior art date
Application number
EA200802402A
Other languages
English (en)
Russian (ru)
Inventor
Дитер Циглер
Клаус Витте
Бертхольд Хохер
Иван Фисер
Original Assignee
Зольвай Фармасьютиклз Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Зольвай Фармасьютиклз Гмбх filed Critical Зольвай Фармасьютиклз Гмбх
Publication of EA200802402A1 publication Critical patent/EA200802402A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EA200802402A 2006-06-19 2007-06-18 Применение антагонистов аденозинового a1-рецептора при индуцируемой радиоконтрастной средой нефропатии EA200802402A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06115673 2006-06-19
EP06126589 2006-12-20
PCT/EP2007/056034 WO2007147809A1 (en) 2006-06-19 2007-06-18 Use of adenosine a1 antagonist in radiocontrast media induced nephropathy

Publications (1)

Publication Number Publication Date
EA200802402A1 true EA200802402A1 (ru) 2009-06-30

Family

ID=38521148

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200802402A EA200802402A1 (ru) 2006-06-19 2007-06-18 Применение антагонистов аденозинового a1-рецептора при индуцируемой радиоконтрастной средой нефропатии

Country Status (11)

Country Link
EP (1) EP2035007A1 (pt)
JP (1) JP2009541256A (pt)
KR (1) KR20090029727A (pt)
AU (1) AU2007263036A1 (pt)
BR (1) BRPI0713126A2 (pt)
CA (1) CA2655016A1 (pt)
EA (1) EA200802402A1 (pt)
IL (1) IL195867A0 (pt)
MX (1) MX2008016255A (pt)
TW (1) TW200808819A (pt)
WO (1) WO2007147809A1 (pt)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR020590A1 (es) * 1998-06-02 2002-05-22 Cadus Pharmaceutical Corp 7-diazapurina-n-6 sustituida, un metodo para su preparacion, composiciones farmaceuticas que la comprenden
AU784878B2 (en) * 1999-12-02 2006-07-13 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 A2A and A3 receptors and uses thereof
CN1263757C (zh) * 2000-12-01 2006-07-12 Osi制药公司 特异于腺苷a1,a2a和a3受体的化合物及其应用
US20040229901A1 (en) * 2003-02-24 2004-11-18 Lauren Otsuki Method of treatment of disease using an adenosine A1 receptor antagonist
AR043880A1 (es) * 2003-04-22 2005-08-17 Solvay Pharm Gmbh Mesilato acido de 4-(4.trans-hidroxiciclohexil) amino-2-fenil-7h-pirrolo (2,3-d) pirimidina y sus formas polimorfas

Also Published As

Publication number Publication date
BRPI0713126A2 (pt) 2012-04-10
TW200808819A (en) 2008-02-16
JP2009541256A (ja) 2009-11-26
IL195867A0 (en) 2009-09-01
CA2655016A1 (en) 2007-12-27
EP2035007A1 (en) 2009-03-18
KR20090029727A (ko) 2009-03-23
AU2007263036A1 (en) 2007-12-27
WO2007147809A1 (en) 2007-12-27
MX2008016255A (es) 2009-01-15

Similar Documents

Publication Publication Date Title
CY1122336T1 (el) Eνωσεις πυρρολιου ως αναστολεις πρωτεϊνικων κινασων εrκ και φαρμακευτικες συνθεσεις που περιεχουν αυτες τις ενωσεις
CY2015016I1 (el) Αναστολεις της κινασης τυροσινης του bruton
BRPI0510170B8 (pt) composto, composição farmacêutica para o tratamento de doenças mediadas pelo receptor muscarínico de acetilcolina e uso do composto
ATE430747T1 (de) 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren
ATE420883T1 (de) Pyrrolopyrimidine verwendbar als protein kinase inhibitoren
CL2007001178A1 (es) Compuestos fusionados derivados de tetrahidro[1,2,4]triazol[4,3-a]pirimidina, moduladores de receptores de glutamato metabotropicos (mglur5); compuestos intermediarios; composicion y combinacion farmaceutica que los comprende; y su uso en la preparacion de medicamentos para tratar enfermedades gastroesofagicas, la ansiedad y dolores.
EA200802184A1 (ru) Фармацевтические композиции с ингибиторами dpp iv
EA200870409A1 (ru) Антагонисты киназы pi3
BRPI0716749A2 (pt) Compostos pirido (2,3-d) pirimidinona e seu uso como inibidores pi3
ATE474835T1 (de) Als inhibitoren von proteinkinasen geeignete aminopyrimidine
CY2013014I1 (el) Εναντιομερικως καθαρες αμινοετεροαρυλικες ενωσεις ως αναστολεις πρωτεϊνικης κινασης
CL2007002887A1 (es) Compuestos derivados de heterociclos, inhibidores de metaloproteinasa de la matriz (mmp); compuesto intermediario; composicion farmaceutica; kit farmaceutico; y uso en la prevencion y tratamiento en afecciones mediadas por metaloproteinasas de la mat
CL2008003023A1 (es) (s)-4-amino-n-(1-(4-clorofenil)-3-hidroxipropil)-1-(7h-pirrolo[2,3-d]pirimidin-4-il)piperidina-4-carboxamida, inhibidor de la proteina quinasa b; procedimiento de preparacion; compuestos intermediarios; composicion farmacéutica que comprende dicho compuesto; y uso para el tratamiento del cancer.
ATE508126T1 (de) Als kinaseinhibitoren geeignete aminopyrimidine
ECSP066468A (es) Antagonistas de receptores muscarínicos de acetilcolina
BRPI0509369A (pt) azaindóis úteis como inibidores de jak e outras proteìna cinases
ATE497961T1 (de) Als proteinkinaseinhibitoren geeignete verbindungen
CL2008001122A1 (es) Compuestos derivados de imidazo[1,2,3-ij]-1,8-naftiridin-4,9-diona; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de infecciones bacterianas.
WO2008018827A8 (en) Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders
DE602006017574D1 (de) Als protein-kinase-inhibitoren nutzbare benzimidazole
BRPI0511124A (pt) pró-drogas de inibidores de erk proteìna cinase de pirrolilpirimidina
ZA200809976B (en) Muscarinic receptor agonists that are effective in the treatment of pain,alzheimers disease and schizophrenia
BRPI0810323A2 (pt) "combinação de ácido pirrolidona 5-carboxílico, uso do ácido pirrolidona 5-carboxílico, composição e seu uso"
CL2007002195A1 (es) Compuesto n-((1r,2s,5r)-5-(isopropil(metil)amino)-2-((s)-2-oxo-3-(6-(trifluorometil)quinazolin-4-ilamino)pirrolidin-1-il)ciclohexil)acetamida; forma cristalina del compuesto; composicion farmaceutica; y uso en el tratamiento de enfermedades tales com
BRPI0412716A (pt) antagonistas de receptor muscarìnico de acetilcolina